Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
AHCO Stock Forecast 2026-2027
$10.90
Current Price
$1.44B
Market Cap
Buy 6
Hold 2
Sell 0
Wall St Analyst Ratings
Distance to AHCO Price Targets
+46.8%
To High Target of $16.00
+28.4%
To Median Target of $14.00
+0.9%
To Low Target of $11.00
AHCO Price Momentum
+6.7%
1 Week Change
+14.4%
1 Month Change
+18.5%
1 Year Change
+9.4%
Year-to-Date Change
-18.8%
From 52W High of $13.43
+28.2%
From 52W Low of $8.51
📊 TOP ANALYST CALLS
Did AHCO Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if AdaptHealth is one of their latest high-conviction picks.
Latest AHCO Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, AHCO has a bullish consensus with a median price target of $14.00 (ranging from $11.00 to $16.00). The overall analyst rating is Strong Buy (8.8/10). Currently trading at $10.90, the median forecast implies a 28.4% upside. This outlook is supported by 6 Buy, 2 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AHCO Analyst Ratings
6
Buy
2
Hold
0
Sell
AHCO Price Target Range
Low
$11.00
Average
$14.00
High
$16.00
Current: $10.90
Latest AHCO Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AHCO.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 6, 2026 | Baird | Eric Coldwell | Outperform | Maintains | $15.00 |
| May 11, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| May 6, 2026 | Canaccord Genuity | Buy | Maintains | $N/A | |
| May 6, 2026 | UBS | Buy | Maintains | $N/A | |
| Apr 13, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Feb 26, 2026 | Leerink Partners | Outperform | Maintains | $N/A | |
| Nov 6, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| May 12, 2025 | Truist Securities | Buy | Maintains | $N/A | |
| May 8, 2025 | RBC Capital | Outperform | Maintains | $N/A | |
| Feb 27, 2025 | Baird | Outperform | Maintains | $N/A | |
| Feb 26, 2025 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Feb 26, 2025 | RBC Capital | Outperform | Maintains | $N/A | |
| Feb 26, 2025 | Truist Securities | Buy | Maintains | $N/A | |
| Feb 13, 2025 | UBS | Buy | Maintains | $N/A | |
| Nov 19, 2024 | RBC Capital | Outperform | Maintains | $N/A | |
| Nov 15, 2024 | Truist Securities | Buy | Maintains | $N/A | |
| Nov 6, 2024 | UBS | Buy | Maintains | $N/A | |
| Nov 6, 2024 | Canaccord Genuity | Buy | Maintains | $N/A | |
| Nov 6, 2024 | Baird | Outperform | Maintains | $N/A | |
| Aug 12, 2024 | RBC Capital | Outperform | Reiterates | $N/A |
AdaptHealth Corp. (AHCO) Competitors
The following stocks are similar to AdaptHealth based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
AHCO
AdaptHealth
mkt cap
1.39B
AdaptHealth Corp. (AHCO) Financial Data
AdaptHealth Corp. has a market capitalization of $1.44B with a P/E ratio of 16.6x. The company generates $3.29B in trailing twelve-month revenue with a -2.4% profit margin.
Revenue growth is +5.4% quarter-over-quarter, while maintaining an operating margin of +0.7% and return on equity of -4.8%.
Valuation Metrics
Market Cap
$1.44B
Enterprise Value
$3.33B
P/E Ratio
16.6x
PEG Ratio
0.1x
Price/Sales
0.4x
Growth & Margins
Revenue Growth (YoY)
+5.4%
Gross Margin
-15.3%
Operating Margin
+0.7%
Net Margin
-2.4%
EPS Growth
+5.8%
Financial Health
Cash/Price Ratio
+3.3%
Current Ratio
0.9x
Debt/Equity
132.1x
ROE
-4.8%
ROA
+2.6%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
AdaptHealth Corp. (AHCO) Business Model
About AdaptHealth Corp.
What They Do
Provides home medical equipment and healthcare solutions.
Business Model
AdaptHealth operates through two main revenue streams: fixed monthly rentals of durable medical equipment and recurring sales of consumable supplies. The company provides essential services, including equipment setup and ongoing support, while primarily billing insurance providers like Medicare and Medicaid.
Additional Information
With approximately 680 locations, AdaptHealth delivers equipment and supplies to millions of patients across the U.S. annually, focusing on areas such as sleep therapy, diabetes management, and chronic respiratory conditions.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
10,900
CEO
Ms. Suzanne M. Foster M.P.H.
Country
United States
IPO Year
N/A
Website
adapthealth.comAdaptHealth Corp. (AHCO) Latest News & Analysis
Latest News
AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call
2 days ago
Quick Summary
AdaptHealth Corp. (NASDAQ: AHCO) will release its Q2 2026 financial results on August 4, 2026, before market open, followed by a teleconference at 8:30 a.m. ET.
Why It Matters
AdaptHealth's upcoming Q2 2026 financial results release and management teleconference could influence stock performance, providing insights into its operations and growth prospects.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Consumer confidence is declining, with the University of Michigan Consumer Sentiment Index at 53.3 in March 2026 and dropping to 49.8 in April 2026, marking a 6.6% decrease.
Why It Matters
Plummeting consumer confidence signals potential economic downturn, impacting spending and corporate earnings, which may lead to stock market volatility and cautious investment strategies.
Source: 24/7 Wall Street
Market Sentiment:
Negative
Quick Summary
AdaptHealth (NASDAQ: AHCO) reported broad organic growth in Q1 but faced higher-than-expected labor costs due to a major capitated contract transition, according to a Bank of America event.
Why It Matters
AdaptHealth's first-quarter organic growth signals strong demand, but rising labor costs may impact profitability, affecting future earnings and investor sentiment.
Source: MarketBeat
Market Sentiment:
Negative
AdaptHealth Corp. (AHCO) Presents at Bank of America Global Healthcare Conference 2026 Transcript
2 months ago
Quick Summary
AdaptHealth Corp. (AHCO) presented at the Bank of America Global Healthcare Conference, providing updates relevant to investors and stakeholders.
Why It Matters
AdaptHealth's presentation at a major healthcare conference signals potential growth opportunities and increased visibility, impacting investor sentiment and stock performance.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
AdaptHealth Corp. (AHCO) held its Q1 2026 earnings call, detailing financial performance and company updates. Further specifics on revenue and guidance will be crucial for investors.
Why It Matters
AdaptHealth's Q1 2026 earnings reveal financial performance, growth prospects, and operational efficiency, influencing stock valuation and investment decisions.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
AdaptHealth Corp. reported strong first-quarter results for 2026, highlighted by the largest de novo expansion in home medical equipment history, successfully meeting an aggressive launch schedule.
Why It Matters
AdaptHealth's record expansion signals strong growth potential and market leadership in home healthcare, likely boosting investor confidence and stock value.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About AHCO Stock
What is AdaptHealth Corp.'s (AHCO) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, AdaptHealth Corp. (AHCO) has a median price target of $14.00. The highest price target is $16.00 and the lowest is $11.00.
Is AHCO stock a good investment in 2027?
According to current analyst ratings, AHCO has 6 Buy ratings, 2 Hold ratings, and 0 Sell ratings. The stock is currently trading at $10.90. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AHCO stock?
Wall Street analysts predict AHCO stock could reach $14.00 in the next 12 months. This represents a 28.4% increase from the current price of $10.90. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is AdaptHealth Corp.'s business model?
AdaptHealth operates through two main revenue streams: fixed monthly rentals of durable medical equipment and recurring sales of consumable supplies. The company provides essential services, including equipment setup and ongoing support, while primarily billing insurance providers like Medicare and Medicaid.
What is the highest forecasted price for AHCO AdaptHealth Corp.?
The highest price target for AHCO is $16.00 from at , which represents a 46.8% increase from the current price of $10.90.
What is the lowest forecasted price for AHCO AdaptHealth Corp.?
The lowest price target for AHCO is $11.00 from at , which represents a 0.9% increase from the current price of $10.90.
What is the overall AHCO consensus from analysts for AdaptHealth Corp.?
The overall analyst consensus for AHCO is bullish. Out of 2 Wall Street analysts, 6 rate it as Buy, 2 as Hold, and 0 as Sell, with a median price target of $14.00.
How accurate are AHCO stock price projections?
Stock price projections, including those for AdaptHealth Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 2:04 AM UTC